Ulrik Harrysson

Ulrik Harrysson has extensive work experience in sales and marketing roles. Ulrik is currently the CEO of SyntheticMR since July 2019. Ulrik also served as a Board Member at Qlife from May 2021 to April 2023. Previously, they held senior leadership positions at Hermes Medical Solutions, including Senior Vice President Global Marketing and Sales from January 2019 to June 2019, and Vice President Sales from April 2018 to December 2018. Prior to that, Ulrik worked at HemoCue AB, where they held various sales director and managerial positions from 2006 until 2018. Ulrik started their career at Pfizer as a Sales Manager from October 2000 to January 2006 and earlier worked as a Sales Manager at Parke-Davis, Division of Warner Lambert Nordic AB from August 1995 to September 2000.

Ulrik Harrysson completed their Master of Science in Business Administration with a focus on Marketing from Jönköping International Business School between 1990 and 1995.